All Curated Mutation Sites in SARS-CoV-2 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
ORF1a
  
ORF1b
  
ORF3a
  
3CLpro
  
3'UTR
  
5'UTR
  
RBD
  
ORF7b-ORF8
  
upstream of N
  
Furin cleavage site
  
E
  
endoRNase
  
Exonuclease
  
S
  
NSP13
  
NSP3
  
M
  
Mpro
  
Methyltransferase
  
N
  
NSP14
  
NSP12
  
Non-coding region
  
NP
  
NS3
  
NS7a
  
NS7b
  
NS8
  
NSP5
  
NSP1
  
NSP10
  
NSP11
  
NSP15
  
NSP16
  
NSP2
  
NSP4
  
NSP6
  
NSP7
  
NSP8
  
NSP9
  
NTD
  
ORF8
  
ORF1ab
  
ORF9b
  
ORF10
  
ORF3
  
ORF6
  
ORF7a
  
ORF7b
  
ORF9
  
ORF9c
  
PLpro
  
RdRp
  
RBM
  
Replicase
  
RNA primase
  

Keyword: COVID-19-37275159
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 37275159 A1501T
S
S
COVID-19
G
R
S
C
L
View
2 37275159 A2862T
S
S
COVID-19
G
R
S
C
L
View
3 37275159 A8530G
S
S
COVID-19
G
R
S
C
L
View
4 37275159 C2042A
S
S
COVID-19
G
R
S
C
L
View
5 37275159 C3438T
S
S
COVID-19
G
R
S
C
L
View
6 37275159 C56T
S
S
COVID-19
G
R
S
C
L
View
7 37275159 D1146D
S
S
COVID-19
G
R
S
C
L
View
8 37275159 F486V
S
S
COVID-19
G
R
S
C
L
View
9 37275159 G1016A
S
S
COVID-19
G
R
S
C
L
View
10 37275159 G10721A
S
S
COVID-19
G
R
S
C
L
View
11 37275159 G339D
S
S
COVID-19
G
R
S
C
L
View
12 37275159 G865A
S
S
COVID-19
G
R
S
C
L
View
13 37275159 N501Y
S
S
COVID-19
G
R
S
C
L
View
14 37275159 P681H
S
S
COVID-19
G
R
S
C
L
View
15 37275159 Q954H
S
S
COVID-19
G
R
S
C
L
View
16 37275159 S373P
S
S
COVID-19
G
R
S
C
L
View
17 37275159 S375F
S
S
COVID-19
G
R
S
C
L
View
18 37275159 T1117C
S
S
COVID-19
G
R
S
C
L
View
19 37275159 T1456G
S
S
COVID-19
G
R
S
C
L
View
20 37275159 T19I
S
S
COVID-19
G
R
S
C
L
View
21 37275159 T3190A
S
S
COVID-19
G
R
S
C
L
View
22 37275159 T376A
S
S
COVID-19
G
R
S
C
L
View
23 37275159 T638G
S
S
COVID-19
G
R
S
C
L
View
24 37275159 V213G
S
S
COVID-19
G
R
S
C
L
View
25 37275159 V289I
S
S
COVID-19
G
R
S
C
L
View
26 37275159 Y505H
S
S
COVID-19
G
R
S
C
L
View
27 37275159 L18L
ORF7b
ORF7b
COVID-19
G
R
S
C
L
View
28 37275159 C15C
ORF7a
ORF7a
COVID-19
G
R
S
C
L
View
29 37275159 T45C
ORF7a
ORF7a
COVID-19
G
R
S
C
L
View
30 37275159 C222T
ORF3a
ORF3a
COVID-19
G
R
S
C
L
View
31 37275159 S74S
ORF3a
ORF3a
COVID-19
G
R
S
C
L
View
32 37275159 T223I
ORF3a
ORF3a
COVID-19
G
R
S
C
L
View
33 37275159 T64T
ORF3a
ORF3a
COVID-19
G
R
S
C
L
View
34 37275159 R3574K
ORF1ab
ORF1ab
COVID-19
G
R
S
C
L
View
35 37275159 S2844G
ORF1ab
ORF1ab
COVID-19
G
R
S
C
L
View
36 37275159 Y1064N
ORF1ab
ORF1ab
COVID-19
G
R
S
C
L
View
37 37275159 L37F
ORF10
ORF10
COVID-19
G
R
S
C
L
View
38 37275159 P13L
N
N
COVID-19
G
R
S
C
L
View
39 37275159 S413R
N
N
COVID-19
G
R
S
C
L
View
40 37275159 D3N
M
M
COVID-19
G
R
S
C
L
View
41 37275159 Q19E
M
M
COVID-19
G
R
S
C
L
View
42 37275159 T9I
E
E
COVID-19
G
R
S
C
L
View
43 37275159 A28271T
upstream of N
COVID-19
G
R
S
C
L
View
44 37275159 C27889T
ORF7b-ORF8
COVID-19
G
R
S
C
L
View
45 37275159 C241T
5'UTR
COVID-19
G
R
S
C
L
View
46 37275159 G142D
S
S
COVID-19
G
R
S
C
L
View
Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.